Zacks Investment Research·2d ago
Here's Why Henry Schein (HSIC) is a Strong Growth StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein is executing a steady growth strategy, with Q2 2026 revenue up 6.7% year-over-year and gross margin expanding to 31.8%, likely driven by a mix shift toward higher-margin products. However, the company's increasing reliance on debt (D/E up from 0.5...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has stabilized at 3-7% with Q2 2026 showing 6.7% growth, while gross margin improved to 31.8% from 29-30% in prior quarters, suggesting a favorable mix shift, though operating leverage remains limited with SG&A growing in line with revenue.
Henry Schein reported adjusted earnings per share of $1.32 and net sales of $3.37b, exceeding expectations and attracting investor interest.
The company's growth is driven by a new CEO, private-label expansion, and operational efficiency under KKR's restructuring.
Henry Schein is leveraging AI-driven software to enhance its business model and create new growth avenues.
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | $1.27+2.4% vs $1.24 | $3.5B+2.5% vs $3.4B |
Q2 2026 May 5, 2026 | $1.32+10.0% vs $1.20 | $3.4B+0.8% vs $3.3B |
Q1 2026 Feb 24, 2026 | $1.34+3.1% vs $1.30 | $3.4B+2.7% vs $3.3B |
Q4 2025 Nov 4, 2025 | $1.38+8.7% vs $1.27 | $3.3B-0.2% vs $3.3B |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein remains a dominant global provider of dental and medical practitioner supplies, with recent share price outperformance versus the S&P 500. HSIC delivered strong Q2 results: revenue up 6.7% to $3.46B, net income and cash flow both meaningfully improved, and all business segments showed growth. Management raised 2026 guidance, now expecting 4.5–5.5% revenue growth and adjusted EPS of $5.29–$5.39, reflecting ongoing operational momentum.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Benchmark HSIC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Henry Schein, Inc. (HSIC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $87.43 | $9.96B | 26.74 | 4.03% | 3.02% | 8.27% | — | |
| $189.85 | $2.94B | 35.42 | 11.89% | 4.35% | 18.27% | — | |
| $2.24 | $171.11M | -0.16 | -74.19% | -39.85% | — | — | |
| $891.23 | $106.23B | 23.22 | 12.36% | 1.12% | — | — | |
| $222.04 | $52B | 30.71 | 299.31% | 0.67% | — | — | |
| $9.95 | $1.99B | -3.32 | -2.98% | -14.99% | -39.8% | — |
Henry Schein, Inc. (HSIC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Henry Schein, Inc. (HSIC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Jul 30, 2026·SEC
May 22, 2026·SEC
Get notified when HSIC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Henry Schein, Inc. (HSIC) stock FAQ — growth, dividends, profitability & financials explained
Henry Schein, Inc. (HSIC) reported $13.60B in revenue for fiscal year 2025. This represents a 1539% increase from $830.0M in 1996.
Henry Schein, Inc. (HSIC) grew revenue by 4.0% over the past year. Growth has been modest.
Yes, Henry Schein, Inc. (HSIC) is profitable, generating $403.0M in net income for fiscal year 2025 (3.0% net margin).
Henry Schein, Inc. (HSIC) has a return on equity (ROE) of 8.3%. This is below average, suggesting room for improvement.
Henry Schein, Inc. (HSIC) generated $539.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
